Hostname: page-component-76d6cb85b7-dqfph Total loading time: 0 Render date: 2026-07-10T14:04:49.582Z Has data issue: false hasContentIssue false

Cannabis use as a potential mediator between childhood adversity and first-episode psychosis: results from the EU-GEI case–control study

Published online by Cambridge University Press:  04 May 2023

Giulia Trotta*
Affiliation:
Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK
Victoria Rodriguez
Affiliation:
Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK
Diego Quattrone
Affiliation:
Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK
Edoardo Spinazzola
Affiliation:
Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK
Giada Tripoli
Affiliation:
Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK
Charlotte Gayer-Anderson
Affiliation:
Health Service and Population Research, Institute of Psychiatry, Psychology, and Neuroscience, King's College London, London, UK
Tom P Freeman
Affiliation:
University of Bath Department of Pharmacy and Pharmacology: University of Bath Department of Life Sciences, Bath, UK
Hannah E Jongsma
Affiliation:
PsyLife Group, Division of Psychiatry, University College London, London, UK
Lucia Sideli
Affiliation:
Department of Human Science, LUMSA University, Rome, Italy
Monica Aas
Affiliation:
Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK
Simona A Stilo
Affiliation:
Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK
Caterina La Cascia
Affiliation:
University of Palermo Department of Biomedicine Neuroscience and Advanced Diagnostics: Universita degli Studi di Palermo Dipartimento di Biomedicina Neuroscienze e Diagnostica avanzata, Palermo, Italy
Laura Ferraro
Affiliation:
University of Palermo Department of Biomedicine Neuroscience and Advanced Diagnostics: Universita degli Studi di Palermo Dipartimento di Biomedicina Neuroscienze e Diagnostica avanzata, Palermo, Italy
Daniele La Barbera
Affiliation:
University of Palermo Department of Biomedicine Neuroscience and Advanced Diagnostics: Universita degli Studi di Palermo Dipartimento di Biomedicina Neuroscienze e Diagnostica avanzata, Palermo, Italy
Antonio Lasalvia
Affiliation:
Section of Psychiatry, Department of Neuroscience, Biomedicine and Movement, University of Verona, Verona, Italy
Sarah Tosato
Affiliation:
Section of Psychiatry, Department of Neuroscience, Biomedicine and Movement, University of Verona, Verona, Italy
Ilaria Tarricone
Affiliation:
University of Bologna Department of Medical and Surgical Sciences: Universita degli Studi di Bologna Dipartimento di Scienze Mediche e Chirurgiche, Bologna, Italy
Giuseppe D'Andrea
Affiliation:
Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK
Andrea Tortelli
Affiliation:
Establissement Public de Sante, Maison Blanche, France
Franck Schürhoff
Affiliation:
Univ Paris Est Creteil (UPEC), AP-HP, Hopitaux Universitaires ‘H. Mondor’, DMU IMPACT, INSERM, IMRB, Translational Neuropsychiatry, Fondation FondaMental, F-94010 Creteil, France
Andrei Szöke
Affiliation:
Univ Paris Est Creteil (UPEC), AP-HP, Hopitaux Universitaires ‘H. Mondor’, DMU IMPACT, INSERM, IMRB, Translational Neuropsychiatry, Fondation FondaMental, F-94010 Creteil, France
Baptiste Pignon
Affiliation:
Univ Paris Est Creteil (UPEC), AP-HP, Hopitaux Universitaires ‘H. Mondor’, DMU IMPACT, INSERM, IMRB, Translational Neuropsychiatry, Fondation FondaMental, F-94010 Creteil, France
Jean-Paul Selten
Affiliation:
Institute for Mental Health, GGZ Rivierduinen, Leiden, The Netherlands
Eva Velthorst
Affiliation:
Mount Sinai School of Medicine Department of Psychiatry: Icahn School of Medicine, New York, NY, USA
Lieuwe de Haan
Affiliation:
Early Psychosis Section, Department of Psychiatry, Amsterdam UMC, Amsterdam, The Netherlands
Pierre-Michel Llorca
Affiliation:
EA 7280 Npsydo, Universite Clermont Auvergne, Clermont-Ferrand, France
Paulo Rossi Menezes
Affiliation:
Department of Preventive Medicine, Faculdade de Medicina, Universidade de São Paulo, São Paulo, Brazil
Cristina M Del Ben
Affiliation:
Department of Neuroscience and Behaviour, Division of Psychiatry, Ribeirao Preto Medical School, University of São Paulo, São Paulo, Brazil
Jose Luis Santos
Affiliation:
Department of Psychiatry, Hospital ‘Virgen de la Luz’, Cuenca, Spain
Manuel Arrojo
Affiliation:
Department of Psychiatry, Psychiatric Genetic Group, Instituto de Investigation Sanitaria de Santiago de Compostela, Complejo Hospitalario Universitario de Santiago de Compostela, Spain
Julio Bobes
Affiliation:
Department of Medicine, Psychiatry Area, Universidad de Oviedo, ISPA, INEUROPA, CIBERSAM, Oviedo, Spain
Julio Sanjuán
Affiliation:
Department of Psychiatry, Centro de Investigation Biomedica en Red de Salud Mental, School of Medicine, Universidad de Valencia, Spain
Miquel Bernardo
Affiliation:
Barcelona Clinic Schizophrenia Unit, Hospital Clinic, Department of Medicine, Neuroscience Institute, University of Barcelona, Institute d'investigations Biomediques, August Pi I Sunyer, Centro de Investigation Biomedica en Red de Salud Mental, Barcelona, Spain
Celso Arango
Affiliation:
Department of Child and Adolescent Psychiatry, Institute of Psychiatry and Mental Health, Hospital General Universitario Gregorio Maranon, School of Medicine, Universidad Complutense, ISGM, CIBERSAM, Madrid, Spain
James B Kirkbride
Affiliation:
PsyLife Group, Division of Psychiatry, University College London, London, UK
Peter B Jones
Affiliation:
CAMEO Early Intervention Service, Cambridgeshire and Peterborough National Health Service Foundation Trust, Cambridge, England
Alexander Richards
Affiliation:
Division of Psychological Medicine and Clinical Neurosciences, MRC Centre for Neuropsychiatric Genetics and Genomics, Cardiff University, Cardiff, UK
Bart P Rutten
Affiliation:
Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Maastricht University, Maastricht, The Netherlands
Jim Van Os
Affiliation:
Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK
Isabelle Austin-Zimmerman
Affiliation:
Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK
Zhikun Li
Affiliation:
Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK
Craig Morgan
Affiliation:
Health Service and Population Research, Institute of Psychiatry, Psychology, and Neuroscience, King's College London, London, UK
Pak C Sham
Affiliation:
Hong Kong University: University of Hong Kong, Hong Kong
Evangelos Vassos
Affiliation:
Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK
Chloe Wong
Affiliation:
Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK
Richard Bentall
Affiliation:
The University of Sheffield Department of Psychology, Sheffield, UK
Helen L Fisher
Affiliation:
Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK
Robin M Murray
Affiliation:
Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK
Luis Alameda
Affiliation:
Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK
Marta Di Forti
Affiliation:
Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK
EU-GEI WP2 Group
Affiliation:
Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK
*
Corresponding author: Giulia Trotta; E-mail: giulia.trotta@kcl.ac.uk
Rights & Permissions [Opens in a new window]

Abstract

Background

Childhood adversity and cannabis use are considered independent risk factors for psychosis, but whether different patterns of cannabis use may be acting as mediator between adversity and psychotic disorders has not yet been explored. The aim of this study is to examine whether cannabis use mediates the relationship between childhood adversity and psychosis.

Methods

Data were utilised on 881 first-episode psychosis patients and 1231 controls from the European network of national schizophrenia networks studying Gene–Environment Interactions (EU-GEI) study. Detailed history of cannabis use was collected with the Cannabis Experience Questionnaire. The Childhood Experience of Care and Abuse Questionnaire was used to assess exposure to household discord, sexual, physical or emotional abuse and bullying in two periods: early (0–11 years), and late (12–17 years). A path decomposition method was used to analyse whether the association between childhood adversity and psychosis was mediated by (1) lifetime cannabis use, (2) cannabis potency and (3) frequency of use.

Results

The association between household discord and psychosis was partially mediated by lifetime use of cannabis (indirect effect coef. 0.078, s.e. 0.022, 17%), its potency (indirect effect coef. 0.059, s.e. 0.018, 14%) and by frequency (indirect effect coef. 0.117, s.e. 0.038, 29%). Similar findings were obtained when analyses were restricted to early exposure to household discord.

Conclusions

Harmful patterns of cannabis use mediated the association between specific childhood adversities, like household discord, with later psychosis. Children exposed to particularly challenging environments in their household could benefit from psychosocial interventions aimed at preventing cannabis misuse.

Information

Type
Original Article
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0), which permits unrestricted re- use, distribution and reproduction, provided the original article is properly cited.
Copyright
Copyright © The Author(s), 2023. Published by Cambridge University Press
Figure 0

Table 1. Sociodemographics, childhood adversities and cannabis use across all included first-episode psychosis cases and unaffected controls

Figure 1

Table 2. Associations between childhood adversities and cannabis use with psychotic disorder (panel A) and associations between childhood adversity and cannabis use (panel B)

Figure 2

Table 3. Mediation analyses displaying the total, direct, indirect effects and the percentage of total effect mediated between advertises and psychosis, via cannabis use patterns

Figure 3

Figure 1. Proportion of the total effect of specific types of adversity on psychosis mediated via lifetime cannabis use, cannabis potency, and frequency of using cannabis. The blue portion of each bar indicates the percentage of the effect mediated (indirect effect). Panel A refers to the main analyses on total exposure to childhood adversity (0–17 years), Panel B refers to the sensitivity analyses restricted to early exposure to childhood adversity (0–12 years).

Supplementary material: File

Trotta et al. supplementary material 1
Download undefined(File)
File 342.5 KB
Supplementary material: File

Trotta et al. supplementary material 2
Download undefined(File)
File 14.8 KB